About Medical Oncology and Immunotherapy Unit, University Hospital of Siena
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Azienda Ospedaliera Universitaria Senese
2
Italian Network for Tumor Biotherapy Foundation
2
iOnctura
2
Clinical Trials at Medical Oncology and Immunotherapy Unit, University Hospital of Siena
During the past decade, Medical Oncology and Immunotherapy Unit, University Hospital of Siena conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
2009-05-01
2013-06-01
Unknown status
29
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
2012-07-01
2015-01-01
Unknown status
29
A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis
2012-12-01
2020-01-01
Unknown status
168
A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients
2015-10-01
2018-10-01
Unknown status
19
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
2020-02-25
2024-04-01
Recruiting
210
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
2022-10-10
2024-04-17
Recruiting
24
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena"
#1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "MedImmune LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Medical Oncology and Immunotherapy Unit, University Hospital of Siena
According to Clinical.Site data, the most researched conditions in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are
"Malignant Mesothelioma" (2 trials), "Brain Metastases" (1 trials), "Metastatic Melanoma" (1 trials), "Metastatic Pancreatic Cancer" (1 trials) and "Myelofibrosis" (1 trials). Many other conditions were trialed in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" in a lesser frequency.
Clinical Trials Intervention Types at Medical Oncology and Immunotherapy Unit, University Hospital of Siena
Most popular intervention types in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Tremelimumab" (2 trials), "Avelumab Injection" (1 trials), "Cisplatin" (1 trials), "Fotemustine" (1 trials) and "Fotemustine and Ipilimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical Oncology and Immunotherapy Unit, University Hospital of Siena
The vast majority of trials in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are
6 trials for "All" genders.
Clinical Trials Status at Medical Oncology and Immunotherapy Unit, University Hospital of Siena
Currently, there are NaN active trials in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Medical Oncology and Immunotherapy Unit, University Hospital of Siena,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical Oncology and Immunotherapy Unit, University Hospital of Siena, 3 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".